Data Bridge Market Research analyses a growth rate in the antipsychotic drugs market in the forecast period 2022-2029. The expected CAGR of antipsychotic drugs market is tend to be around 8.5% in the mentioned forecast period. The market was valued at USD 13,473.10 million in 2021, and it would grow upto USD 25805.39 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Antipsychotic drugs, also termed as neuroleptics or major tranquilizers, are the class of CNS therapeutics widely used to concomitant relief from psychosis and other mental illness symptoms by interrupting the activity of dopaminergic pathways of the brain. It is of great importance to the healthcare sector and it is expected to grow in the forecast period.

Read More : https://www.databridgemarketresearch.com/reports/global-antipsychot...

Drivers

Increase in Bipolar Disorders
According to the reports of Medscape in 2019, the incidence rate of bipolar disorder was predicted to be around 0.3–1.5%. However, in recent years, the prevalence of the bipolar disorder has increased substantially. This boost the market growth.

Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Recent Developments

Janssen Pharmaceutical received approval from the European Commission (EC) in November 2021 for long-acting atypical antipsychotic therapy BYANNLI which is used as a treatment for patients, preferably adults, suffering from schizophrenia, who are clinically stable on 1-monthly paliperidone palmitate or 3-monthly paliperidone palmitate.

Global Antipsychotic Drugs Market Scope
The antipsychotic drugs market is segmented on the basis of indication, drug class, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

Schizophrenia
Bipolar Disorders
Major Depression
Dementia
Others
Drug Class

First Generation
Second Generation
Third Generation
End User

Hospitals
Homecare
Specialty Clinics
Others
Distribution Channel

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

Key players operating in the antipsychotic drugs market include:

Johnsons & Johnsons Services Inc (U.S.)
Boehringer Ingelheim International GmbH (Germany)
Sun Pharmaceutical Industries Ltd. (India)
Sanofi (France)
AstraZeneca (U.K.)
GlaxoSmithKline Plc. (U.K.)
Novartis AG (Switzerland)
Pfizer Inc. (U.S.)
Amneal Pharmaceuticals LLC. (U.S.)
Alvogen (U.S)
Hikma Pharmaceuticals PLC (U.K.)
Mylan N.V. (U.S.)
Janssen Global Services, LLC (Belgium)
Bristol Myers Squibb Company (U.S.)
Bayer AG (Germany)

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- [email protected]